Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results
March 02, 2023 16:01 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, March 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics to Present at Cowen’s 43rd Annual Health Care Conference
February 23, 2023 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023
February 16, 2023 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Launches Max Read™ Kits for Single Cell Sequencing on the G4 at AGBT
February 06, 2023 07:00 ET
|
Singular Genomics Systems, Inc.
- New next-generation sequencing kit maximizes throughput and decreases the cost for single cell experiments - - Company announces increased quality and throughput specifications of the G4 Sequencing...
Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT
February 06, 2023 07:00 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Joins the 10x Genomics Compatible Partner Program
February 02, 2023 08:00 ET
|
Singular Genomics Systems, Inc.
– Demonstrates compatibility of the G4 Sequencing Platform with 10x Genomics Single Cell Applications – SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC),...
Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue
January 09, 2023 06:00 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference
December 21, 2022 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results
November 07, 2022 16:01 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...
Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022
October 24, 2022 16:05 ET
|
Singular Genomics Systems, Inc.
SAN DIEGO, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower...